Southeast Asia (ASEAN)
The work we do
ASEAN is working towards greater vaccine security and self-reliance through its ASEAN Vaccine Security and Self-Reliance (AVSSR) initiative, which strengthens regional manufacturing, regulatory cooperation, and vaccine access.
RVMC works with the Thai National Vaccine Institute, the regional focal point for AVSSR, to support these ambitions. We help connect national manufacturing plans with regional vaccine needs and market opportunities, working with partners such as the World Bank Group to align financing and technical support. We also support efforts to strengthen regulatory cooperation and explore regional pooled procurement, drawing on lessons from Africa, and Latin America and the Caribbean.
Market Shaping Strategy for ASEAN
The 2026 Market-Shaping Strategy for ASEAN, developed by RVMC and the Clinton Health Access Initiative (CHAI), highlights the region's established manufacturing base, with 24 active vaccine manufacturers. However, much of its production capacity is concentrated in a small number of manufacturers, while fragmented procurement and regulatory systems make it difficult to supply vaccines across borders.
The next step is to make better use of these capabilities by strengthening manufacturing in priority areas, improving regulatory cooperation, and coordinating vaccine demand. This can help regional manufacturers remain commercially viable while maintaining the capacity to respond to future outbreaks.
RVM Insights
The RVM Insights Hub brings together evidence to help you understand what's changing, where challenges remain, and what comes next.
Explore our data and insights on vaccine manufacturing in ASEAN, covering manufacturing capabilities and regional supply, as well as the gaps and opportunities for progress.
1
The number of vaccine manufacturers in ASEAN producing five or more vaccines, with integrated production, capacity for over 70 million doses annually, and active exports.
29%
The share of regional vaccine demand in ASEAN, met by manufacturers within the region
14 of 18
The number of regional priority diseases for which at least one commercial vaccine is produced by a regional manufacturer
Related Resources
Other regions of focus
Africa
Africa aims to produce 60% of the vaccines it needs by 2040, yet regional manufacturers currently supply just 1% of demand. Discover how RVMC is supporting efforts to turn this ambition into sustainable vaccine supply.
LAC
With established manufacturing capabilities and regional procurement mechanisms, LAC has strong foundations to build on. Learn how RVMC is supporting sustainable regional supply and sharing lessons across regions.
